Wambolt & Associates’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$247K Buy
1,803
+8
+0.4% +$1.08K 0.08% 160
2025
Q1
$257K Buy
1,795
+7
+0.4% +$1.02K 0.09% 160
2024
Q4
$246K Buy
1,788
+8
+0.4% +$1.17K 0.08% 167
2024
Q3
$273K Buy
1,780
+7
+0.4% +$1.06K 0.07% 175
2024
Q2
$257K Buy
1,773
+7
+0.4% +$1K 0.07% 182
2024
Q1
$259K Sell
1,766
-22
-1% -$3.16K 0.08% 201
2023
Q4
$244K Sell
1,788
-62
-3% -$8.06K 0.08% 219
2023
Q3
$238K Buy
1,850
+34
+2% +$4.51K 0.09% 215
2023
Q2
$241K Sell
1,816
-169
-9% -$22.3K 0.09% 222
2023
Q1
$260K Buy
+1,985
New +$259K 0.09% 222

Other funds holding XLV

Wambolt & Associates's XLV Position: Q2 2025 in Review

Wambolt & Associates increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 0.45% in Q2 2025, buying an estimated $1.08K and bringing the position to 1,803 shares worth $247K. The position accounts for 0.08% of the portfolio, ranked #160.

Wambolt & Associates first reported a position in XLV in Q1 2023 and has held it in 10 quarters since. The position peaked at $273K in Q3 2024. 1,678 funds tracked by Wall St. Rank hold XLV as of Q2 2025.

  • Wambolt & Associates held 1,803 shares of State Street Health Care Select Sector SPDR ETF worth $247K as of Q2 2025.
  • Wambolt & Associates bought 8 State Street Health Care Select Sector SPDR ETF shares in Q2 2025, an estimated $1.08K.
  • State Street Health Care Select Sector SPDR ETF made up 0.08% of Wambolt & Associates's portfolio in Q2 2025, its #160 holding.
  • Wambolt & Associates first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2023 and has held it in 10 quarters since.
  • Wambolt & Associates's State Street Health Care Select Sector SPDR ETF position peaked at $273K in Q3 2024.
  • 1,678 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2025.

Based on Wambolt & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.